BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37903316)

  • 21. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance.
    Ruf B; Roggia C; Schroeder C; Mattern S; Fend F; Klag T; Götz M
    J Gastrointest Cancer; 2023 Jun; 54(2):520-527. PubMed ID: 35499650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?
    Zhang Q; Yang Z; Karamchandani DM
    Ann Diagn Pathol; 2020 Apr; 45():151473. PubMed ID: 31986421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventive gastrectomy in patients with gastric cancer risk due to genetic alterations of the E-cadherin gene defect.
    Schwarz A
    Langenbecks Arch Surg; 2003 Mar; 388(1):27-32. PubMed ID: 12690477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decision-making and regret in patients with germline
    Gamble LA; Grant RRC; Samaranayake SG; Fasaye GA; Koh C; Korman L; Asif B; Heller T; Hernandez JM; Blakely AM; Davis JL
    J Med Genet; 2023 Mar; 60(3):241-246. PubMed ID: 35817563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations.
    Huntsman DG; Carneiro F; Lewis FR; MacLeod PM; Hayashi A; Monaghan KG; Maung R; Seruca R; Jackson CE; Caldas C
    N Engl J Med; 2001 Jun; 344(25):1904-9. PubMed ID: 11419427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDH1 and hereditary diffuse gastric cancer: a narrative review.
    Gregory SN; Davis JL
    Chin Clin Oncol; 2023 Jun; 12(3):25. PubMed ID: 37303221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case report: acute abdominal pain in a 37-year-old patient and the consequences for his family.
    Niemeyer E; Mofid H; Zornig C; Burandt EC; Stein A; Block A; Volk AE
    BMC Gastroenterol; 2020 May; 20(1):129. PubMed ID: 32362280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review of the indications for genetic testing and prophylactic gastrectomy among patients with hereditary diffuse gastric cancer.
    Seevaratnam R; Coburn N; Cardoso R; Dixon M; Bocicariu A; Helyer L
    Gastric Cancer; 2012 Sep; 15 Suppl 1():S153-63. PubMed ID: 22160243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance and Surgical Considerations in Hereditary Diffuse Gastric Cancer.
    Gamble LA; Davis JL
    Gastrointest Endosc Clin N Am; 2022 Jan; 32(1):163-175. PubMed ID: 34798984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk.
    Barber ME; Save V; Carneiro F; Dwerryhouse S; Lao-Sirieix P; Hardwick RH; Caldas C; Fitzgerald RC
    J Pathol; 2008 Nov; 216(3):286-94. PubMed ID: 18825658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic total gastrectomy for individuals with germline CDH1 mutation.
    Pandalai PK; Lauwers GY; Chung DC; Patel D; Yoon SS
    Surgery; 2011 Mar; 149(3):347-55. PubMed ID: 20719348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hereditary diffuse gastric cancer associated with E-cadherin germline mutation: a case report.
    Black MD; Kaneshiro R; Lai JI; Shimizu DM
    Hawaii J Med Public Health; 2014 Jul; 73(7):204-7. PubMed ID: 25089230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
    van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
    Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgery for Hereditary Diffuse Gastric Cancer: Long-Term Outcomes.
    Forrester JD; Foster D; Ford JM; Longacre TA; Ladabaum U; Fry S; Norton JA
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic Total Gastrectomy: a Prospective Cohort Study of Long-Term Impact on Quality of Life.
    Muir J; Aronson M; Esplen MJ; Pollett A; Swallow CJ
    J Gastrointest Surg; 2016 Dec; 20(12):1950-1958. PubMed ID: 27752808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A prospective study of total gastrectomy for CDH1-positive hereditary diffuse gastric cancer.
    Chen Y; Kingham K; Ford JM; Rosing J; Van Dam J; Jeffrey RB; Longacre TA; Chun N; Kurian A; Norton JA
    Ann Surg Oncol; 2011 Sep; 18(9):2594-8. PubMed ID: 21424370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary gastric cancer.
    Carneiro F
    Pathologe; 2012 Nov; 33 Suppl 2():231-4. PubMed ID: 23052347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
    Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
    Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview on new progress of hereditary diffuse gastric cancer with
    Hu MN; Hu SH; Zhang XW; Xiong SM; Deng H
    Tumori; 2020 Oct; 106(5):346-355. PubMed ID: 32811340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic gastrectomy for hereditary diffuse gastric cancer syndrome.
    Newman EA; Mulholland MW
    J Am Coll Surg; 2006 Apr; 202(4):612-7. PubMed ID: 16571431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.